Page last updated: 2024-08-23

triazinate and Cancer of Gastrointestinal Tract

triazinate has been researched along with Cancer of Gastrointestinal Tract in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruckner, HW; Lokich, JJ; Stablein, DM1
Benjamin, RS; Bodey, GP; Burgess, MA; Hall, SW; Loo, TL; Tenczynski, TF; Valdivieso, M1

Trials

1 trial(s) available for triazinate and Cancer of Gastrointestinal Tract

ArticleYear
Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolate.
    Cancer chemotherapy and pharmacology, 1978, Volume: 1, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Folic Acid Antagonists; Gastrointestinal Neoplasms; Humans; Kinetics; Lung Neoplasms; Male; Middle Aged; Triazines

1978

Other Studies

1 other study(ies) available for triazinate and Cancer of Gastrointestinal Tract

ArticleYear
Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
    Cancer treatment reports, 1982, Volume: 66, Issue:9

    Topics: Adenocarcinoma; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Humans; Male; Methotrexate; Middle Aged; Myeloproliferative Disorders; Prognosis; Random Allocation; Razoxane; Triazines

1982